Liu Fei, Yu Jianer, Bai Li, Xue Zheng, Zhang Xinguang
Pediatrics Shanghai Academy, Shanghai Municipal Hospital of Traditional Chinese Medicine affiliated to Shanghai TCM University, Shanghai, 200071, China.
Wuxi Municipal Hospital of Traditional Chinese Medicine, Wuxi, 214001, China.
BMC Complement Altern Med. 2015 Jul 16;15:234. doi: 10.1186/s12906-015-0755-8.
Pingchuan Formula (PCF) is a traditional Chinese recipe. PCF improves chronic airway inflammation by correcting the imbalance of T-helper cell ratio. The purpose of this study was to investigate the effect of PCF on pathological changes in the lungs of asthmatic mice in terms of Treg/Th17 balance.
A bronchial asthma BALB/c mouse model was established using the ovalbumin excitation method. Distilled water (for MDL group) and drugs (for DEX or PCF group) were administered by gavage immediately after the first excitation. Mice were sacrificed after 7 and 28 d treatment. Lung tissues and bronchoalveolar lavage fluid were collected and lung pathological changes were observed after hematoxylin and eosin staining. Differential cell counts, concentrations of interleukins-6, -17, -23 and TGF-β in bronchoalveolar lavage fluid were determined by enzyme-linked immunosorbent assay. Expression of transcriptional factors Foxp3 and RORγt was determined by immunohistochemistry and immunoblot.
An asthma model was successfully established. After 7 or 28 d treatment, lung pathological changes were improved and concentration of interleukins-6, -17, -23 and TGF-β in bronchoalveolar lavage fluid significantly decreased in the PCF group. RORγt expression in lung tissue was decreased in the PCF group, while Foxp3 expression increased (all P values<0.05 compared with the MDL group). There was no significant difference between the PCF and DEX group except that mice in the PCF group lost less bodyweight.
Treatment with PCF downregulates RORγt, elevates Foxp3 expression, reduces interleukins-6, -17, -23 and TGF-β in bronchoalveolar lavage fluid, thus restoring Th17/Treg balance, improving airway inflammation and reducing asthma symptoms.
平喘方(PCF)是一种中药方剂。PCF通过纠正辅助性T细胞比例失衡来改善慢性气道炎症。本研究旨在从调节性T细胞(Treg)/辅助性T细胞17(Th17)平衡方面探讨PCF对哮喘小鼠肺部病理变化的影响。
采用卵清蛋白激发法建立支气管哮喘BALB/c小鼠模型。首次激发后立即灌胃给予蒸馏水(模型对照组)和药物(地塞米松或PCF组)。治疗7天和28天后处死小鼠。收集肺组织和支气管肺泡灌洗液,苏木精-伊红染色后观察肺部病理变化。采用酶联免疫吸附测定法测定支气管肺泡灌洗液中细胞分类计数、白细胞介素-6、-17、-23和转化生长因子-β的浓度。采用免疫组织化学和免疫印迹法检测转录因子叉头框蛋白3(Foxp3)和维甲酸相关孤儿受体γt(RORγt)的表达。
成功建立哮喘模型。治疗7天或28天后,PCF组肺部病理变化得到改善,支气管肺泡灌洗液中白细胞介素-6、-17、-23和转化生长因子-β的浓度显著降低。PCF组肺组织中RORγt表达降低,而Foxp3表达增加(与模型对照组相比,所有P值均<0.05)。PCF组和地塞米松组之间无显著差异,只是PCF组小鼠体重减轻较少。
PCF治疗可下调RORγt表达,上调Foxp3表达,降低支气管肺泡灌洗液中白细胞介素-6、-17、-23和转化生长因子-β水平,从而恢复Th17/Treg平衡,改善气道炎症,减轻哮喘症状。